About Spark Biomedical
Spark Biomedical is a company based in Houston (United States) founded in 2018. Spark Biomedical has raised $31.23 million across 7 funding rounds from investors including NIH, HHS and Wellcome. The company has 18 employees as of December 31, 2022. Spark Biomedical offers products and services including Sparrow Ascent. Spark Biomedical operates in a competitive market with competitors including Ceribell, INBRAIN Neuroelectronics, Freespira, Kernel and BrainScope, among others.
- Headquarter Houston, United States
- Employees 18 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spark Biomedical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.23 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 4 more
-
Employee Count
18
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spark Biomedical
Spark Biomedical offers a comprehensive portfolio of products and services, including Sparrow Ascent.
Provides non-invasive treatment for opioid withdrawal symptoms.
Funding Insights of Spark Biomedical
Spark Biomedical has successfully raised a total of $31.23M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spark Biomedical
Spark Biomedical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Wellcome.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wave Ventures is engaged in empowering innovators through strategic investments.
|
Locked | Locked | Locked | |
|
Pathway to Cures is focused on funding therapies for inheritable blood disorders.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Spark Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spark Biomedical
Investment portfolio details for Spark Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spark Biomedical
Detailed financials for Spark Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spark Biomedical Comparisons
Peer comparison for Spark Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spark Biomedical
Spark Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, INBRAIN Neuroelectronics, Freespira, Kernel and BrainScope, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Panic disorders are treated via breathing device and mobile app.
|
|
| Locked | Locked | Locked |
Multimodal brain measurement technology is developed for neuromedicine applications.
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
|
| Locked | Locked | Locked |
Minimally invasive bioelectronics are developed for mental health disorders.
|
Detailed competitors of Spark Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spark Biomedical
Complete news archive for Spark Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spark Biomedical
Spark Biomedical was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Spark Biomedical is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Daniel Powell is the current CEO of Spark Biomedical.
Spark Biomedical is a funded company, having raised a total of $31.23M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Spark Biomedical is 18.
Spark Biomedical was founded in 2018 and is based in Houston, United States. The company operates in the biomedical sector, focusing on neurostimulation technology. A wearable device is developed to address opioid withdrawal by reducing associated symptoms and supporting addiction alleviation. Operations center on device innovation for clinical applications in addiction treatment.
Spark Biomedical's top competitors include Ceribell, INBRAIN Neuroelectronics and BrainScope.
Spark Biomedical offers Sparrow Ascent.
Spark Biomedical has 5 investors. Key investors include NIH, HHS, Wellcome, Wave Ventures, and Pathway to Cures.